Patent · US Active

Therapeutic compounds

US9951019B2 · kind B2 · utility

0Cited by
0References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 24, 2016
Grant dateApr 24, 2018
Priority date
Expiry dateJun 24, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/12
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention provides compounds of formula (I):wherein, A, C, D, X, and Y have any of the values defined in the specification, and salts thereof. The compounds are SIRT2 inhibitors and are useful for treating SIRT2 associated conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.